43 related articles for article (PubMed ID: 11136915)
21. Plasma homocysteine concentrations in acute and convalescent changes of central retinal vein occlusion in a Chinese population.
Dong N; Xu B; Tang X
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4057-62. PubMed ID: 24906854
[TBL] [Abstract][Full Text] [Related]
22. Blood levels of homocysteine, cysteine, glutathione, folic acid, and vitamin B12 in the acute phase of atherothrombotic stroke.
Salemi G; Gueli MC; D'Amelio M; Saia V; Mangiapane P; Aridon P; Ragonese P; Lupo I
Neurol Sci; 2009 Aug; 30(4):361-4. PubMed ID: 19484186
[TBL] [Abstract][Full Text] [Related]
23. Serum vitamin B12 and folic Acid levels in acute cerebral atherothrombotic infarction.
Kocer A; Ince N; Canbulat CE; Sargin M
Tohoku J Exp Med; 2004 Oct; 204(2):155-61. PubMed ID: 15383696
[TBL] [Abstract][Full Text] [Related]
24. Homocysteine, MTHFR C677 T, vitamin B12, and folate levels in Thai children with ischemic stroke: a case-control study.
Sirachainan N; Tapanapruksakul P; Visudtibhan A; Chuansumrit A; Cheeramakara C; Atamasirikul K; Chotsuppakarn S; Areekul S
J Pediatr Hematol Oncol; 2006 Dec; 28(12):803-8. PubMed ID: 17164649
[TBL] [Abstract][Full Text] [Related]
25. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
[TBL] [Abstract][Full Text] [Related]
26. Is plasma homocysteine a modifiable risk factor for stroke?
Hankey GJ
Nat Clin Pract Neurol; 2006 Jan; 2(1):26-33. PubMed ID: 16932518
[TBL] [Abstract][Full Text] [Related]
27. Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.
Stehouwer DA
Drugs Aging; 2000 Apr; 16(4):251-60. PubMed ID: 10874520
[TBL] [Abstract][Full Text] [Related]
28. Homocysteine and risk of stroke.
Perry IJ
J Cardiovasc Risk; 1999 Aug; 6(4):235-40. PubMed ID: 10501275
[TBL] [Abstract][Full Text] [Related]
29. Homocysteine and atherothrombosis.
Falk E; Zhou J; Møller J
Lipids; 2001; 36 Suppl():S3-11. PubMed ID: 11837989
[TBL] [Abstract][Full Text] [Related]
30. Clinical usefulness of plasma homocysteine in vascular disease.
Hankey GJ; Eikelboom JW; Ho WK; van Bockxmeer FM
Med J Aust; 2004 Sep; 181(6):314-8. PubMed ID: 15377241
[TBL] [Abstract][Full Text] [Related]
31. Homocysteine, oxidative stress, and vascular disease.
Welch GN; Upchurch GR; Loscalzo J
Hosp Pract (1995); 1997 Jun; 32(6):81-2, 85, 88-92. PubMed ID: 9194803
[TBL] [Abstract][Full Text] [Related]
32. Can lowering homocysteine levels reduce the incidence of stroke?
Sarkar PK; Lambert L
J Clin Pharm Ther; 1999 Oct; 24(5):331-8. PubMed ID: 10583695
[TBL] [Abstract][Full Text] [Related]
33. Novel risk factors for stroke: homocysteine, inflammation, and infection.
Goldstein LB
Curr Atheroscler Rep; 2000 Mar; 2(2):110-4. PubMed ID: 11122733
[TBL] [Abstract][Full Text] [Related]
34. Homocysteine as atherothrombotic agent: is the bark worse than the bite?
Ubbink JB; Delport R
Nutrition; 2000; 16(7-8):672-4. PubMed ID: 10906593
[No Abstract] [Full Text] [Related]
35. Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke.
Meiklejohn DJ; Vickers MA; Dijkhuisen R; Greaves M
Stroke; 2001 Jan; 32(1):57-62. PubMed ID: 11136915
[TBL] [Abstract][Full Text] [Related]
36. Homocysteine and risk of cardiovascular disease.
Andreotti F; Burzotta F; Manzoli A; Robinson K
J Thromb Thrombolysis; 2000 Jan; 9(1):13-21. PubMed ID: 10590184
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
